➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Moodys
Merck
McKinsey
Mallinckrodt

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

Patent: 8,002,676

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,002,676
Title:Strikeable exercise apparatus
Abstract: The strikeable exercise apparatus provides several exercise benefits, all capable of being practiced indoors or out. The apparatus provides a plurality of bats and a plurality of hexagons, each of which may be padded. The bats\' shapes are shaped to provide as much striking area as is possible. The abrupt taper disposed at the cylinder second end provides as much room for the handle as is possible within the length of each bat. The apparatus is especially useful in providing for the development of core power, as well as power in the extremities by providing that each dual-handled hexagon can be wielded as is chosen, as can each bat. The plurality of weights of the bats and hexagons importantly provide for the strongest as well as the not so strong to enjoy a myriad of activities that provide for both core power development and extremity development.
Inventor(s): Corona; Mariano (Woodland Hills, CA), Corona; Yolanda (Woodland Hills, CA)
Assignee:
Application Number:12/835,225
Patent Claims:see list of patent claims

Details for Patent 8,002,676

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
AstraZeneca
Dow
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.